Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 16/20 | 0.64 |
| ▸ | NPY1R | P25929 | 10/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.64 |
| ▸ | NPY2R | P49146 | 6/20 | 0.64 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30006452 | 0.98 | NPY4R (0.67) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL7594031 | 0.95 | NPY4R (0.66) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL7594012 | 0.95 | NPY4R (0.66) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL20630936 | 0.91 | NPY4R (0.67) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL31314376 | 0.90 | NPY4R (0.65) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL31031473 | 0.88 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29630454 | 0.88 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29461973 | 0.88 | NPY4R (0.63) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29540421 | 0.88 | NPY4R (0.63) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30309259 | 0.88 | NPY4R (0.65) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |